Therapeutic Potential of Galantamine for Managing the Complications Associated with Ischemic Stroke / (Record no. 608668)

000 -LEADER
fixed length control field 02412nam a22001577a 4500
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 610
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Ahsan, Mehwish
245 ## - TITLE STATEMENT
Title Therapeutic Potential of Galantamine for Managing the Complications Associated with Ischemic Stroke /
Statement of responsibility, etc. Mehwish Ahsan
264 ## - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Islamabad :
Name of producer, publisher, distributor, manufacturer SMME- NUST;
Date of production, publication, distribution, manufacture, or copyright notice 2024.
300 ## - PHYSICAL DESCRIPTION
Extent 104p.
Other physical details Soft Copy
Dimensions 30cm
500 ## - GENERAL NOTE
General note Ischemic stroke remains the leading cause of illness and second leading cause of death<br/>worldwide. Previous research has shown that galantamine has neuroprotective properties,<br/>reducing neuronal death and damage in neurodegenerative conditions and improving cognitive<br/>function in Alzheimer's disease patients. The investigation looked into the possible<br/>mechanisms by which this medication could reduce cell death. Wistar rats were subjected to a<br/>temporary 30-minute occlusion of the right middle cerebral artery (MCA) and given an oral<br/>dose of 5mg/kg for three weeks. After 18 days of surgery, behavioral assessments were carried<br/>out. Galantamine enhanced grip strength, motor function, and muscle strength in rats. Spatial<br/>memory and object recognition examinations revealed cognitive improvements, thus indicating<br/>enhanced cognitive abilities and memory retention. Moreover, rats subjected to galantamine<br/>treatment displayed increased sociability and heightened locomotor activity during social<br/>interaction and open-field assessments. Molecular analysis of galantamine treatment in rats<br/>showed an upregulation of SOD2 expression, suggesting enhanced antioxidant defense, and a<br/>downregulation of TLR4 expression, suggesting a reduction in neuroinflammation, supporting<br/>the anti-inflammatory properties of galantamine. The histological analysis done with H&E<br/>staining of brain tissue revealed enhanced tissue morphology in the galantamine-treated group,<br/>signifying the neuroprotective effects of galantamine. The reduction in neuronal damage,<br/>edema, and inflammatory cell infiltration further supported this observation. The results<br/>demonstrate that galantamine, potentially through the preservation of a functional cholinergic<br/>system, mitigated the impairments caused by stroke in a basic learning and memory test by<br/>decreasing cellular death.
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element MS Biomedical Sciences (BMS)
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Supervisor : Dr. Aneeqa Noor
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://10.250.8.41:8080/xmlui/handle/123456789/42579">http://10.250.8.41:8080/xmlui/handle/123456789/42579</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Koha item type Thesis
Holdings
Withdrawn status Permanent Location Current Location Shelving location Date acquired Full call number Barcode Koha item type
  School of Mechanical & Manufacturing Engineering (SMME) School of Mechanical & Manufacturing Engineering (SMME) E-Books 03/12/2024 610 SMME-TH-999 Thesis
© 2023 Central Library, National University of Sciences and Technology. All Rights Reserved.